Viveon Health Acquisition (VHAQ) Competitors $10.00 0.00 (0.00%) (As of 11/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends VHAQ vs. TCRX, STRO, MOLN, CYBN, MGNX, SOPH, ZNTL, GNFT, SLN, and INBXShould you be buying Viveon Health Acquisition stock or one of its competitors? The main competitors of Viveon Health Acquisition include TScan Therapeutics (TCRX), Sutro Biopharma (STRO), Molecular Partners (MOLN), Cybin (CYBN), MacroGenics (MGNX), SOPHiA GENETICS (SOPH), Zentalis Pharmaceuticals (ZNTL), Genfit (GNFT), Silence Therapeutics (SLN), and Inhibrx (INBX). These companies are all part of the "pharmaceutical products" industry. Viveon Health Acquisition vs. TScan Therapeutics Sutro Biopharma Molecular Partners Cybin MacroGenics SOPHiA GENETICS Zentalis Pharmaceuticals Genfit Silence Therapeutics Inhibrx TScan Therapeutics (NASDAQ:TCRX) and Viveon Health Acquisition (NYSE:VHAQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings. Which has better earnings and valuation, TCRX or VHAQ? Viveon Health Acquisition has lower revenue, but higher earnings than TScan Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTScan Therapeutics$21.05M10.37-$89.22M-$1.06-3.89Viveon Health AcquisitionN/AN/A-$610KN/AN/A Does the media refer more to TCRX or VHAQ? In the previous week, TScan Therapeutics had 21 more articles in the media than Viveon Health Acquisition. MarketBeat recorded 21 mentions for TScan Therapeutics and 0 mentions for Viveon Health Acquisition. TScan Therapeutics' average media sentiment score of 0.65 beat Viveon Health Acquisition's score of 0.00 indicating that TScan Therapeutics is being referred to more favorably in the media. Company Overall Sentiment TScan Therapeutics Positive Viveon Health Acquisition Neutral Do insiders and institutionals believe in TCRX or VHAQ? 82.8% of TScan Therapeutics shares are owned by institutional investors. Comparatively, 22.1% of Viveon Health Acquisition shares are owned by institutional investors. 2.8% of TScan Therapeutics shares are owned by insiders. Comparatively, 75.3% of Viveon Health Acquisition shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, TCRX or VHAQ? TScan Therapeutics has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, Viveon Health Acquisition has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Is TCRX or VHAQ more profitable? Viveon Health Acquisition has a net margin of 0.00% compared to TScan Therapeutics' net margin of -1,188.88%. Viveon Health Acquisition's return on equity of 0.00% beat TScan Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets TScan Therapeutics-1,188.88% -58.72% -36.02% Viveon Health Acquisition N/A N/A N/A Do analysts rate TCRX or VHAQ? TScan Therapeutics presently has a consensus price target of $12.00, suggesting a potential upside of 191.26%. Given TScan Therapeutics' stronger consensus rating and higher probable upside, research analysts clearly believe TScan Therapeutics is more favorable than Viveon Health Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TScan Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Viveon Health Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in TCRX or VHAQ? TScan Therapeutics received 31 more outperform votes than Viveon Health Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformTScan TherapeuticsOutperform Votes3179.49% Underperform Votes820.51% Viveon Health AcquisitionN/AN/A SummaryTScan Therapeutics beats Viveon Health Acquisition on 9 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Viveon Health Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for VHAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VHAQ vs. The Competition Export to ExcelMetricViveon Health AcquisitionPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$56.56M$6.49B$5.07B$19.96BDividend YieldN/A8.11%4.99%3.49%P/E RatioN/A4.8587.8636.42Price / SalesN/A374.821,228.8217.94Price / CashN/A52.5939.5121.28Price / Book-3.1110.216.944.59Net Income-$610,000.00$153.61M$119.12M$985.93M7 Day PerformanceN/A-2.00%-1.84%0.45%1 Month PerformanceN/A-7.47%-3.65%1.05%1 Year Performance-12.28%31.80%31.64%24.67% Viveon Health Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VHAQViveon Health AcquisitionN/A$10.00flatN/AN/A$56.56MN/A0.002High Trading VolumeTCRXTScan Therapeutics2.9905 of 5 stars$4.12-2.1%$12.00+191.3%-10.6%$223.02M$21.05M0.00100STROSutro Biopharma4.5351 of 5 stars$2.67-1.1%$12.14+354.8%-3.6%$222.64M$153.73M0.00240Analyst ForecastAnalyst RevisionMOLNMolecular Partners0.2312 of 5 stars$5.20-4.8%$4.50-13.5%+19.8%$220.24M$7.84M0.00180CYBNCybin1.4678 of 5 stars$11.14+1.2%$138.00+1,139.3%N/A$219.91MN/A-1.6750Analyst ForecastAnalyst RevisionGap UpMGNXMacroGenics3.8708 of 5 stars$3.28-5.7%$7.63+132.5%-57.0%$218.42M$58.75M0.00430SOPHSOPHiA GENETICS1.4237 of 5 stars$3.17-3.1%$6.50+105.0%-14.6%$213.78M$62.37M0.00520ZNTLZentalis Pharmaceuticals2.5896 of 5 stars$3.13+4.7%$10.00+219.5%-71.1%$213.08MN/A0.00160Analyst RevisionGNFTGenfit1.4608 of 5 stars$4.31+1.2%$13.00+201.6%+27.1%$212.95M$41.31M0.00120SLNSilence Therapeutics3.646 of 5 stars$6.93-0.6%$57.20+725.4%-27.1%$208.60M$31.55M0.00100Analyst ForecastNews CoverageHigh Trading VolumeINBXInhibrx1.2884 of 5 stars$14.04-1.7%N/A-36.9%$206.86M$1.63M0.00166 Related Companies and Tools Related Companies TScan Therapeutics Alternatives Sutro Biopharma Alternatives Molecular Partners Alternatives Cybin Alternatives MacroGenics Alternatives SOPHiA GENETICS Alternatives Zentalis Pharmaceuticals Alternatives Genfit Alternatives Silence Therapeutics Alternatives Inhibrx Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:VHAQ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveon Health Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveon Health Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VHAQ Stock Alerts